Intravitreal clearance and volume of distribution of compounds in rabbits: In silico prediction and pharmacokinetic simulations for drug development

被引:110
作者
del Amo, Eva M. [1 ,2 ]
Vellonen, Kati-Sisko [2 ]
Kidron, Heidi [1 ]
Urtti, Arto [1 ,2 ]
机构
[1] Univ Helsinki, Ctr Drug Res, Div Pharmaceut Biosci, Helsinki, Finland
[2] Univ Eastern Finland, Sch Pharm, Kuopio 70211, Finland
基金
芬兰科学院;
关键词
lntravitreal injection; Volume of distribution; Clearance; QSPR; Ocular drug delivery; Pharmacokinetic simulation; INTRAOCULAR PHARMACOKINETICS; RETINAL TOXICITY; DELIVERY-SYSTEM; HALF-LIFE; INJECTION; MODEL; INFLAMMATION; GANCICLOVIR; GENTAMICIN; CARBENICILLIN;
D O I
10.1016/j.ejpb.2015.01.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The aims of this research were to (1) create a curated universal database of intravitreal volumes of distribution (V-ss,V- ivt) and clearances (CLivt) of small molecular weight compounds and macromolecules and (2) to develop quantitative structure property relationship (QSPR) and pharmacokinetic models for the estimation of vitreal drug concentrations based on the compound structure. V-ss,V- ivt and CLivt values were determined from the available literature on intravitreal drug administration using compartmental models and curve fitting. A simple QSPR model for CLivt of small molecular weight compounds was obtained with two descriptors: LogD(7.4) and hydrogen bond donor capacity. The model predicted the internal and external test sets reliably with a mean fold error of 1.50 and 1.33, respectively (Q(2)Y = 0.62). For 80% of the compounds the V-ss,V- (ivt) was 1.18-2.28 ml; too narrow range for QSPR model building. Integration of the estimated V-ss,V- (ivt) and predicted CLivt parameters into pharmacokinetic simulation models allows prediction of vitreous drug concentrations after intravitreal administration. The present work presents for the first time a database of CLivt and V-ss,V- ivt values and the dependence of the CLivt values on the molecular structure. The study provides also useful in silico tools to investigate a priori the intravitreal pharmacokinetic profiles for intravitreally injected candidate compounds and drug delivery systems. (C) 2015 Elsevier B.V. All rights reserved.
引用
收藏
页码:215 / 226
页数:12
相关论文
共 74 条
  • [1] AGUILAR HE, 1995, RETINA-J RET VIT DIS, V15, P428
  • [2] ASSIL KK, 1991, INVEST OPHTH VIS SCI, V32, P2891
  • [3] Disposition of short-chain aliphatic alcohols in rabbit vitreous by ocular microdialysis
    Atluri, H
    Mitra, AK
    [J]. EXPERIMENTAL EYE RESEARCH, 2003, 76 (03) : 315 - 320
  • [4] Pharmacokinetics of intravitreal ranibizumab (Lucentis)
    Bakri, Sophie J.
    Snyder, Melissa R.
    Reid, Joel M.
    Pulido, Jose S.
    Ezzat, Mohamed K.
    Singh, Ravinder J.
    [J]. OPHTHALMOLOGY, 2007, 114 (12) : 2179 - 2182
  • [5] Pharmacokinetics of intravitreal bevackumab (avastin)
    Bakri, Sophie J.
    Snyder, Melissa R.
    Reid, Joel M.
    Pulido, Jose S.
    Singh, Ravinder J.
    [J]. OPHTHALMOLOGY, 2007, 114 (05) : 855 - 859
  • [7] BARZA M, 1982, INVEST OPHTH VIS SCI, V22, P720
  • [8] PHARMACOKINETICS OF AZTREONAM IN RABBIT EYES
    BARZA, M
    MCCUE, M
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (04) : 468 - 473
  • [9] USE OF TOBRAMYCIN IN ERADICATING EXPERIMENTAL BACTERIAL ENDOPHTHALMITIS
    BENNETT, TO
    PEYMAN, GA
    [J]. ALBRECHT VON GRAEFES ARCHIV FUR KLINISCHE UND EXPERIMENTELLE OPHTHALMOLOGIE, 1974, 191 (02): : 93 - 107
  • [10] Ocular safety profile and intraocular pharmacokinetics of an antagonist of EphB4/EphrinB2 signalling
    Brar, Manpreet
    Cheng, Lingyun
    Yuson, Ritchie
    Mojana, Francesca
    Freeman, William R.
    Gill, Parkash S.
    [J]. BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (12) : 1668 - 1673